myEmploymentHub

Senior Director, Team Lead, CDK4/6 Portfolio, US Breast Cancer

Pfizer

Location
United States - New York - New York City; United States - Pennsylvania - Collegeville
Source
workday

ROLE SUMMARY

Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future.


Breast cancer is the most common cancer affecting women in the US, and IBRANCE, our first-in-class CDK 4/6 inhibitor, has been prescribed to ~200,000 patients in the US since launch. In 2026, IBRANCE contributed >$2B in net revenue to Pfizer Oncology and continues to be a market leader despite intensifying competition. With the June 2026 FDA approval of the PATINA HER2+ indication, IBRANCE is now the only CDK4/6 inhibitor indicated for HR+ metastatic breast cancer regardless of HER2 status.


The next three years are the most consequential in the history of Pfizer’s breast cancer business. IBRANCE faces IRA effectuation and LOE in 2027, and atirmociclib, our CDK4-selective inhibitor, is the portfolio’s planned successor. Phase 2 randomized results from the FOURLIGHT-1 study of atirmociclib, plus fulvestrant in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (MBC) who had received prior CDK 4/6 inhibitor-based treatment were presented at ESMO. These results further support atirmociclib as a potential first-in-class cell cycle inhibitor backbone for HR+, HER2- MBC and Pfizer’s development strategy in earlier lines of therapy. A Phase 3 study in frontline MBC is ongoing and an additional Phase 3 study in early breast cancer is planned to evaluate atirmociclib in combination with giredestrant, an investigational oral selective oestrogen receptor.


The same oncologists, accounts and treatment decisions are involved in both. This is a P&L and people-management leadership role that demands a strong enterprise leader. The colleague who leads this team will set a multi-year strategic vision, make thoughtful trade-off and resource prioritization decisions for both brands, and influence senior leadership across the wider organization. The role leads that transition as one integrated strategy: maximizing IBRANCE value through the PATINA launch/10 year heritage campaign, IRA and LOE while building the market, evidence and organization that atirmociclib will need.


The IBRANCE and atirmociclib commercial leader will pave the way internally and guide the cross functional team to innovate in all aspects of engagement across all stakeholder groups.



ROLE RESPONSIBILITIES

This Senior Director, Team Lead role reports to the VP, US Breast Cancer Franchise Lead and is an excellent opportunity for an experienced, collaborative and strategic leader to own the IBRANCE P&L and the atirmociclib pre-launch investment plan: own forecasting, OpEx and resource allocation, manage the revenue and expense trade-offs of LOE, and ensure every dollar released from IBRANCE is redeployed deliberately against portfolio priorities. The role leads a team of 6-8 HCP & patient marketers at the Director and Sr. Manager level. Atirmociclib is a critical launch for the Oncology portfolio over the next 5 years.


1. Optimize ~2B IBRANCE net revenue through 10 year heritage, IRA and LOE

  • Define and manage IBRANCE strategy and tactical execution through LOE, including identifying and executing incremental growth opportunities.
  • Lead the LOE plan: scenarios, customer and account communication, partnerships, patient marketing and generic-entry readiness, in partnership with Market Access, Trade, Legal and Medical.
  • Directly accountable for P&L Management and driving performance of marketing tactics and set investment levels against a clear profit-optimization framework, maximizing ROI through thoughtful trade-offs and redirecting savings to franchise priorities on an agreed timeline.

2. Build atirmociclib launch readiness & set a multi-year strategy

  • Launch excellence in frontline MBC and early breast cancer indications with a potential multibillion dollar revenue as a preferred next-generation backbone.
  • Set a multi-year strategic vision to anticipate the shifts in the HR+ve / HER2 -ve competitive landscape, evolving standards of care, and shape the brand strategy today to launch this multi-indication brand over the next 3 years.
  • Strategize proactively with Market Access, Pricing and Trade to shape the atirmociclib pricing and contracting strategy, channel and distribution model, and gross-to-net plan, ensuring the launch is positioned for durable access and profitability
  • Lead US HCP and account strategy for atirmociclib: positioning against generic CDK4/6 inhibitors, segmentation, target customers and the launch plan.
  • Shape the first-line market before approval with disease-state education and pre-launch engagement, in partnership with Medical Affairs and Clinical Development.
  • Define launch-readiness milestones, evidence needs and the investment case in partnership with Global, Market Access, Commercial Insights and Sales.
  • Continuously own the measurement and impact of marketing initiatives — using advanced analytics to generate learnings and drive continuous improvement against brand objectives.
  • Ensure marketing materials are compelling, compliant and appropriate across all channels, including AI-enabled and omnichannel touchpoints.
  • Identify strategic customer insights through collaboration with Medical, Market analytics, AI/data-science, field force and prescribers, and translate them into actionable strategies.

3. Own the integrated patient and advocacy strategy for HR+ve disease

  • Develop an integrated patient strategy & partner with enterprise patient support functions towards an intentional, end-to-end patient experience that removes barriers to starting and staying on therapy, leverages learning from Ibrance, and is scalable to future launches
  • Lead patient marketers focused on direct to patient, patient support and adherence programs, to protect patient continuity for Ibrance and set up a launch strategy for atirmociclib.
  • Connect the patient journey — build the operating model, metrics and feedback loops that connect field sales and marketing execution directly to patients and hold both accountable to shared commercial outcomes.

4. Run the transition as one strategy

  • Define how customers, accounts and field effort move from IBRANCE to atirmociclib, including the customer segments, messages and timing for each stage.
  • Align closely with BC Sales and Key account director leadership on annual sales meetings that incorporate Customer facing colleagues feedback, grow the CDK class, maintain IBRANCE class leadership and re-weight field focus as the portfolio changes.
  • Lead the development of the customer insight plan in partnership with analytics and Customer facing colleagues, and use it to evolve the strategic and tactical approach and anticipate how HCPs will choose among CDK inhibitors during the transition & in preparation for atirmo.
  • Work with the leads of other franchise assets (for example KAT6i/prifetrastat in the post-CDK4/6 setting and TUKYSA) so patient journeys connect and messages are consistent.

4. Lead people and the CDK4/6 portfolio

  • Directly lead and develop a talented team of director- and senior-manager-level marketers to achieve high performance and maximize potential.
  • Manage, engage and coach the team to achieve high performance and maximize team potential, and plan roles, development and succession as the work moves from IBRANCE to atirmociclib.
  • Actively foster a positive team culture and collaboration across the broader US BC marketing team.
  • Member of the BC franchise leadership team & broader Oncology Business extended leadership team.



BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including the ability to influence and collaborate with peers, develop and coach others, and oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

  • Bachelor’s degree required, and 12+ years of pharmaceutical industry experience required, or Master's degree and 10+ years
  • Pharmaceutical/biotech commercial experience, including US brand management & P&L accountability.
  • Deep understanding of US market dynamics including specialty channels, oncology organized customers and payers
  • INNOVATION & AI FLUENCY: Demonstrated use of AI and advanced analytics to sharpen customer insight, targeting, forecasting and investment decisions, and a track record of championing innovative solutions that change how the team works
  • Demonstrated success developing, executing and measuring complex marketing programs and championing innovative solutions
  • COMMERCIAL EXCELLENCE: Proven track record of identifying customer needs and extracting and translating key insights into meaningful strategies and tactics
  • LEADERSHIP: 5+ years of direct or matrix management or coaching of marketing colleagues at all levels (Manager to Director) and commitment to fostering team engagement, team culture and developing people
  • INTERNAL AMBASSADOR: Collaborative team player with demonstrated ability to engage experts from a wide range of cross-functional areas to improve business performance and find a path forward
  • Strong analytical skills; detail and action oriented, creative, flexible, self-motivated
  • Excellent verbal and written communication skills for a wide range of audiences including senior level executives
  • Is a role model for the Pfizer Values



PREFERRED QUALIFICATIONS

  • Oncology marketing experience
  • Experience managing a brand through loss of exclusivity
  • Experience leading a US oncology or specialty product launch, from pre-launch market shaping through first-line commercialization
  • Experience designing, piloting or scaling new go-to-market models (e.g., omnichannel or AI-enabled customer engagement, hybrid field/digital coverage, account-based approaches) and applying them through a brand lifecycle transition
  • Experience leading patient marketing, including DTC/DTP strategy, patient support and adherence programs, and advocacy engagement, with the ability to integrate patient and HCP strategies into one customer plan



Non-Standard Work Schedule, Travel or Environment Requirements

  • Comfort working in a fast-paced environment and making complex decisions quickly
  • Ability to synthesize and analyze complex data and understand trends and mathematical calculations
  • Ability to work on a computer for extended periods using common applications (Outlook, Excel, PowerPoint)
  • Ability to travel domestically and internationally as needed for congresses, sales meetings and customer interactions
  • Pending Pfizer policies, travel is required: International & domestic travel of up to 25%



Other Job Details:

Last Date to Apply for Job: November 30th, 2026

Additional Location Information: New York, NY; Collegeville, PA

Eligible for Relocation Package: No

Position is hybrid and will require to work 2 to 3 days per week on site

#LI-PFE

The annual base salary for this position ranges from $230,900.00 to $384,800.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

This role is posted in multiple locations. If you are applying for the role in an secondary job posting location where pay transparency regulations apply, your Talent Advisor will share the local pay information with you during the first interview.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.

Pfizer endeavors to make www.pfizer.com/careers accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing, please email disabilityrecruitment@pfizer.com. This is to be used solely for accommodation requests with respect to the accessibility of our website, online application process and/or interviewing. Requests for any other reason will not be returned.

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.

Marketing and Market Research